Swisse Continues To Grow In China While Sales Stabilize in Australia
Australian-heritage supplements brand Swisse saw sales grow double-digits in China in the first half of 2021, while also returning to growth in Australia and New Zealand.
You may also be interested in...
Having cemented leading positions in China and Australia, Swisse Wellness' owners H&H Group are looking to grow the reach of the premium supplements brand across Europe and Asia-Pacific. The firm is targeting 25% growth for Swisse this year after double-digit growth in 2018.
UK consumer healthcare industry association PAGB is preparing its response to a "wide ranging" consultation on the future of how medical devices are regulated in the country. MHRA says it wants a system that streamlines product approvals while still prioritizing patient safety.
The latest appointments in Europe's consumer health industry: GSK promotes Davide Fanelli to lead its business in Spain; Stada appoints Marc van Boven to a newly-created role; and Sanofi hires Theresa von Fugle to manage its OTC operation in Germany.